Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

100 trials with published results (20%)

Research Maturity

311 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

9.2%

47 terminated out of 509 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

26%

132 trials in Phase 3/4

Results Transparency

32%

100 of 311 completed with results

Key Signals

100 with results87% success47 terminated

Data Visualizations

Phase Distribution

299Total
Not Applicable (83)
Early P 1 (7)
P 1 (13)
P 2 (64)
P 3 (82)
P 4 (50)

Trial Status

Completed311
Recruiting58
Unknown57
Terminated47
Withdrawn14
Not Yet Recruiting12

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 311 completed trials

Clinical Trials (509)

Showing 20 of 20 trials
NCT07399977Not ApplicableRecruitingPrimary

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

NCT05701917Not ApplicableRecruitingPrimary

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

NCT06950697Recruiting

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

NCT07506473Not ApplicableNot Yet Recruiting

Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial

NCT05449327Not ApplicableCompletedPrimary

Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty

NCT05628207Recruiting

Evaluation of the SCALED (SCaling AcceptabLE cDs)

NCT05735639Phase 4RecruitingPrimary

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

NCT05900388Not Yet RecruitingPrimary

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

NCT05171075Phase 3TerminatedPrimary

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

NCT05881798Recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

NCT06765681Active Not Recruiting

An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

NCT06299111Phase 2CompletedPrimary

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

NCT06129760Not ApplicableSuspended

Glioblastoma Remote Monitoring and Care - Research Protocol

NCT07499661Not ApplicableNot Yet Recruiting

Pulmonary Embolism in Patients With Acute Heart Failure: A Pragmatic Cluster-Randomized Trial (PEHF Study)

NCT05351749Not ApplicableCompleted

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

NCT06166537Not ApplicableRecruitingPrimary

GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

NCT07350499Recruiting

Aspiration Thrombectomy Using the Symphony or Prodigy System

NCT06753786Not ApplicableRecruitingPrimary

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

NCT06073366CompletedPrimary

Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study

NCT04022915Phase 1Terminated

PET Fibrin Imaging of DVT and PE

Scroll to load more

Research Network

Activity Timeline